Cited by 673Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchCardiovascular Function and Risk Factors

The DOI matches its Crossref record, with a small difference in title or year; 6 of the 6 references it cites were found in a registry or an index.

Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes?

Haffner, Steven M.·1990·JAMA

DOI 10.1001/jama.1990.03440210043030

Open this paper in CoChat — free account

Abstract

Although type II diabetes is associated with both microvascular and macrovascular complications, duration of diabetes and severity of glycemia are strongly associated only with the former. Since prediabetic individuals are hyperinsulinemic, and since hyperinsulinemia may be a cardiovascular risk factor, we hypothesized that prediabetic individuals might have an atherogenic pattern of risk factors even before the onset of clinical diabetes, thereby explaining the relative lack of an association of macrovascular complications with either glycemic severity or disease duration. We documented the cardiovascular risk factor status of 614 initially nondiabetic Mexican Americans who later participated in an 8-year follow-up of the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease. Individuals who were nondiabetic at the time of baseline examination, but who subsequently developed type II diabetes (ie, confirmed prediabetic subjects, n = 43), had higher levels of total and lowdensity lipoprotein cholesterol, triglyceride, fasting glucose and insulin, 2-hour glucose, body mass index, and blood pressure, and lower levels of high-density lipoprotein cholesterol than subjects who remained nondiabetic (n = 571). Most of these differences persisted after adjustment for obesity and/or level of glycemia, but were abolished after adjustment for fasting insulin concentration. When subjects with impaired glucose tolerance at baseline (n = 106) were eliminated, the more atherogenic pattern of cardiovascular risk factors was still evident (and statistically significant) among initially normoglycemic prediabetic subjects. These results indicate that prediabetic subjects have an atherogenic pattern of risk factors (possibly caused by obesity, hyperglycemia, and especially hyperinsulinemia), which may be present for many years and may contribute to the risk of macrovascular disease as much as the duration of clinical diabetes itself. (JAMA. 1990;263:2893-2898)

Integrity signals

Registry

Crossref · 10.1001/jama.1990.03440210043030

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The publisher hasn’t deposited this paper’s reference list.

Sorted by citations

Items 201–300 of 673

Role of IGF-1 in glucose regulation and cardiovascular disease
Abbas, A., Grant, P. J., & Kearney, M. T. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.8.1135 · Cited by 61
Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis
Zhang, H., Bai, Z., Zhu, L., Liang, Y., Fan, X., Li, J., Wen, H., Shi, T., Zhao, Q., & Wang, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112665 · Cited by 60
Does Psychological Stress Cause Diabetes?
Wales, J. K. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00439.x · Cited by 59
High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study
Eliasson, M., Jansson, J., Lindahl, B., & Stegmayr, B. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-19 · Cited by 58
Lifestyle intervention to prevent diabetes: intensive AND cost effective
Wylie‐Rosett, J., Herman, W. H., & Goldberg, R. B. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000203890.27267.eb · Cited by 57
The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia
Jagannathan, R., Sevick, M. A., Fink, D. A., Dankner, R. S., Chetrit, A., Roth, J., Buysschaert, M., & Bergman, M. (2016) · Acta Diabetologica · doi:10.1007/s00592-015-0829-6 · Cited by 63
Insulin sensitizers may prevent metabolic inflammation
Colca, J. R. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.002 · Cited by 56
Hyperinsulinemic syndrome: The metabolic syndrome is broader than you think
Kelly, C. T., Mansoor, J., Dohm, G. L., Chapman, W. H. H., Pender, J. R., & Pories, W. J. (2014) · Surgery · doi:10.1016/j.surg.2014.04.028 · Cited by 58
Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men
Fizelova, M., Miilunpohja, M., Kangas, A. J., Soininen, P., Kuusisto, J., Ala‐Korpela, M., Laakso, M., & Stančáková, A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.034 · Cited by 55
Effects of Modifying Triglycerides and Triglyceride-rich Lipoproteins on Cardiovascular Outcomes
Abdel-Maksoud, M. F., Sazonov, V., Gutkin, S. W., & Hokanson, J. E. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318165e2e7 · Cited by 54
Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in Type 2 diabetes
Phillips, C. M., Murugasu, G., Owens, D., Collins, P. B., Johnson, A., & TOMKIN, G. H. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00275-0 · Cited by 54
Maternal metabolic factors and the association with gestational diabetes: a systematic review and meta-analysis
Habibi, N., Mousa, A., Tay, C. T., Khomami, M. B., Patten, R. K., Andraweera, P. H., Wassie, M., Vandersluys, J., Aflatounian, A., Bianco‐Miotto, T., et al. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3532 · Cited by 53
Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models
Kusumoto, K., Igata, H., Ojima, M., Tsuboi, A., Imanishi, M., Yamaguchi, F., Sakamoto, H., Kuroita, T., Kawaguchi, N., Nishigaki, N., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.014 · Cited by 52
Long Term Trends and Racial/Ethnic Disparities in the Prevalence of Obesity
Wong, R. J., Chou, C., & Ahmed, A. (2014) · Journal of Community Health · doi:10.1007/s10900-014-9870-6 · Cited by 52
Nonpharmacologic Therapy and Exercise in the Prevention of Type 2 Diabetes
Tuomilehto, J. O. (2009) · Diabetes Care · doi:10.2337/dc09-s308 · Cited by 53
Should glycated haemoglobin (HbA1c) be used to detect people with type 2 diabetes mellitus and impaired glucose regulation?
Mostafa, S. A., Davies, M. J., Srinivasan, B. T., Carey, M., Webb, D. R., & Khunti, K. (2010) · Postgraduate Medical Journal · doi:10.1136/pgmj.2009.091215 · Cited by 55
Macrovascular angiopathy in children and adolescents with type 1 diabetes
Giannini, C., Mohn, A., Chiarelli, F., & Kelnar, C. J. H. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1195 · Cited by 55
Health risks and interventions in prediabetes: A review
Mahat, R. K., Singh, N., Arora, M., & Rathore, V. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.041 · Cited by 56
Long-term effects of a high-carbohydrate diet and exercise on insulin action in older subjects with impaired glucose tolerance
Hughes, V., Fiatarone, M., Fielding, R., Ferrara, C., Elahi, D., & Evans, W. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.2.426 · Cited by 52
Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy
Zeymer, U., Schwarzmaier-D'Assie, A., Petzinna, D., & Chiasson, J. L. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000140712.71649.5a · Cited by 51
High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study
Arcavi, L., Behar, S., Caspi, A., Reshef, N., Boyko, V., & Knobler, H. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.09.013 · Cited by 51
The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre?
Reaven, G. M. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719601 · Cited by 50
Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats
Ellis, C. G., Goldman, D., Hanson, M., Stephenson, A. H., Milkovich, S., Benlamri, A., Ellsworth, M. L., & Sprague, R. S. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01239.2009 · Cited by 50
Impaired Glucose Tolerance and the Likelihood of Nonfatal Stroke and Myocardial Infarction
Qureshi, A. I., Giles, W. H., & Croft, J. B. (1998) · Stroke · doi:10.1161/01.str.29.7.1329 · Cited by 50
Increased amino acids levels and the risk of developing of hypertriglyceridemia in a 7-year follow-up
Mook-Kanamori, D. O., Römisch‐Margl, W., Kastenmüller, G., Prehn, C. P., Petersen, A. K., Illig, T., Gieger, C., Wang‐Sattler, R., Meisinger, C., Peters, A., et al. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0044-7 · Cited by 51
Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study
Brahimaj, A., Ligthart, S., Ikram, M. A., Albert Hofman, D., Franco, O. H., Sijbrands, E. J. G., Kavousi, M., & Dehghan, A. (2016) · Diabetes Care · doi:10.2337/dc16-1295 · Cited by 50
Impact of age on cardiovascular risk: implications for cardiovascular disease management
Tuomilehto, J. O. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.03.006 · Cited by 49
Detection of Abnormal Glucose Tolerance in Africans Is Improved by Combining A1C With Fasting Glucose: The Africans in America Study
Sumner, A. E., Thoreson, C. K., O'Connor, M. Y., Ricks, M., Chung, S. T., Tulloch-Reid, M. K., Lozier, J. N., & Sacks, D. B. (2014) · Diabetes Care · doi:10.2337/dc14-1179 · Cited by 47
Cardiovascular Disease in Diabetes
Bloomgarden, Z. T. (2010) · Diabetes Care · doi:10.2337/dc10-zb04 · Cited by 49
What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome?
Windler, E. E. T. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.06.003 · Cited by 49
Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment
Kudolo, G. B., Bressler, P., & DeFronzo, R. A. (1997) · Journal of Lipid Mediators and Cell Signalling · doi:10.1016/s0929-7855(97)00023-0 · Cited by 48
Inadequacies of absolute threshold levels for diagnosing prediabetes
Bergman, M. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1013 · Cited by 47
31st G. Heiner Sell Lectureship: Secondary Medical Consequences of Spinal Cord Injury
Bauman, W. A., Korsten, M. A., Radulovic, M., Schilero, G. J., Wech, J., & Spungen, A. M. (2012) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci1804-354 · Cited by 47
Serum C-peptide levels and risk of death among adults without diabetes mellitus
Min, J., & Min, K. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121950 · Cited by 47
Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus—An effect probably mediated by direct platelet PPARγ activation
Khanolkar, M., Morris, R. H. K., Thomas, A. W., Bolusani, H., Roberts, A. W., Geen, J., Jackson, S. K., & Evans, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.020 · Cited by 46
Insulin resistance and maximal oxygen uptake
Seibæk, M., Vestergaard, H., Burchardt, H., Sloth, C., Torp-Pedersen, C. T., Nielsen, S. L., Hildebrandt, P. R., & Pedersen, O. B. (2003) · Clinical Cardiology · doi:10.1002/clc.4960261107 · Cited by 46
Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes
Alserius, T., Hammar, N., Nordqvist, T., & Ivert, T. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.02.010 · Cited by 45
Impaired fasting glycaemia in middle-aged women: a prospective study
Guthrie, J., Ball, M. A. Z., DUDLEY, E. C., Garamszegi, C. V., Ml, W., Dennerstein, L., & Burger, H. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801569 · Cited by 45
Insulin resistance is not related to plasma homocysteine concentration in healthy premenopausal women
Tanrıkulu-Kılıç, F., Bekpınar, S., Ünlüçerçi, Y., & Orhan, Y. (2006) · Physiological Research · doi:10.33549/physiolres.930745 · Cited by 45
Pregravid cardiometabolic risk profile and risk for gestational diabetes mellitus
Hedderson, M. M., Darbinian, J. A., Quesenberry, C. P., & Ferrara, A. M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.03.037 · Cited by 45
The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population
Qian, Y., Lin, Y., Zhang, T., Bai, J., Chen, F., Zhang, Y., Luo, S., & Shen, H. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-139 · Cited by 44
Cardiovascular Disease Risk Stratification With Stress Single-Photon Emission Computed Tomography Technetium-99m Tetrofosmin Imaging in Patients With the Metabolic Syndrome and Diabetes Mellitus
Shaw, L. J., Berman, D. S., Hendel, R. C., Alazraki, N. P., Krawczynska, E. G., Borges‐Neto, S., Maddahi, J., & Cerqueira, M. D. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.041 · Cited by 44
Serum lipid and hsCRP levels in prediabetes – impaired fasting glucose (IFG) and impaired glucose tolerance (IGT)
Chakarova, N. Y., Tankova, T. I., Atanassova, I., & Dakovska, L. N. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.04.005 · Cited by 44
Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease
von Bibra, H., Diamant, M., Scheffer, P. G., Siegmund, T., & Schumm‐Draeger, P. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.045 · Cited by 44
Is Type 2 Diabetes Mellitus a Vascular Condition?
Hu, F. B., & Stampfer, M. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000094360.38911.71 · Cited by 44
Update on Type 2 Diabetes as a Cardiovascular Disease Risk Equivalent
Kuusisto, J., & Laakso, M. (2013) · Current Cardiology Reports · doi:10.1007/s11886-012-0331-5 · Cited by 43
Cardiometabolic risk assessment: An approach to the prevention of cardiovascular disease and diabetes mellitus
Vasudevan, A. R., & Ballantyne, C. M. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80063-8 · Cited by 43
Diabetes Mellitus and Acute Coronary Syndrome: Lessons From Randomized Clinical Trials
Sethi, S. S., Akl, E., & Farkouh, M. E. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0272-9 · Cited by 44
Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: protective effect of HDL cholesterol in women
Fagot‐Campagna, A., Narayan, K. M. V., Hanson, R. L., Imperatore, G., Howard, B. V., Nelson, R. G., Pettitt, D. J., & Knowler, W. C. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)05978-3 · Cited by 42
Improvement of Insulin Resistance and Early Atherosclerosis in Patients after Gastric Banding
Hanusch‐Enserer, U., Cauza, E., Spak, M., Endler, G., Dunky, A., Tura, A., Wagner, O. F., Rosén, H., Pacini, G., & Prager, R. (2004) · Obesity Research · doi:10.1038/oby.2004.36 · Cited by 43
Risk of a Recurrent Cardiovascular Event in Individuals With Type 2 Diabetes or Intermediate Hyperglycemia
van der Heijden, A. A. W. A., Riet, E. V. ‘., Bot, S. D. M., Cannegieter, S. C., Stehouwer, C. D. A., Baan, C. A., Dekker, J. M., & Nijpels, G. (2013) · Diabetes Care · doi:10.2337/dc12-2691 · Cited by 42
Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure
Hoffmann, I. S., Jimenez, E., & Cubeddu, L. (2001) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001193 · Cited by 41
A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI)
Nijpels, G., Boorsma, W., Dekker, J. M., Kostense, P. J., Bouter, L. M., & Heine, R. J. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.839 · Cited by 42
Diabetic Dyslipidaemia
Best, J. D., & Neal, D. N. O. (2000) · Drugs · doi:10.2165/00003495-200059050-00006 · Cited by 41
Redefining the Diagnosis of Diabetes Using Glycated Hemoglobin
Fonseca, V. A., Inzucchi, S. E., & Ferrannini, E. (2009) · Diabetes Care · doi:10.2337/dc09-9034 · Cited by 42
The clustering of Cardiovascular, Renal, Adipo-Metabolic Eye and Liver disease with type 2 diabetes
Thomas, M. C. (2022) · Metabolism · doi:10.1016/j.metabol.2021.154961 · Cited by 41
Critical appraisal of the estimation of body composition via two-, three-, and four-compartment models
Withers, R. T., Laforgia, J., & Heymsfield, S. B. (1999) · American Journal of Human Biology · doi:10.1002/(sici)1520-6300(1999)11:2 · Cited by 86
Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis
McKeown, N. M., Dashti, H. S., Ma, J., Haslam, D. E., Jong, J. C. K., Smith, C. E., Tanaka, T., Graff, M., Lemaître, R. N., Rybin, D. V., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4475-0 · Cited by 40
Insulin Stimulation of Hepatic Triacylglycerol Secretion in the Insulin‐Replete State
Zammit, V. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04263.x · Cited by 40
Strong association of C‐reactive protein with body mass index and 2‐h post‐challenge glucose in non‐diabetic, non‐smoker subjects without hypertension
Hashimoto, K., Kasayama, S., Yamamoto, H., Kurebayashi, S., Kawase, I., & Koga, M. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01212.x · Cited by 39
Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation – The Hoorn Study
Beijers, H. J. B. H., Ferreira, I., Spronk, H. M. H., Bravenboer, B., Dekker, J. M., Nijpels, G., Cate, H. T., & Stehouwer, C. D. A. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.07.033 · Cited by 38
Prevalence, detection, treatment, and control of hypertension in human immunodeficiency virus (HIV)-infected patients attending HIV clinics in the Western Cape Province, South Africa
Mutemwa, M., Peer, N., de Villiers, A., Mukasa, B., Matsha, T. E., Mills, E. J., & Kengne, A. P. (2018) · Medicine · doi:10.1097/md.0000000000012121 · Cited by 38
Dyslipidaemia and cardiovascular risk in diabetes
Cullen, P., von Eckardstein, A., Souris, S., Schulte, H., & Assmann, G. (1999) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.00030.x · Cited by 39
Association of prediabetes with diffuse coronary narrowing and small-vessel disease
Ertan, Ç., Özeke, Ö., Gül, M., Aras, D., Topaloğlu, S., Kisacik, H. L., Demir, A. D., Aydoğdu, S., & Özin, B. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.06.015 · Cited by 37
Prevalence of prehypertension and associated cardiovascular risk profiles among prediabetic Omani adults
Ganguly, S. S., Al‐Shafaee, M., Bhargava, K., & Duttagupta, K. K. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-108 · Cited by 37
Insulin resistance caused by lipotoxicity is related to oxidative stress and endoplasmic reticulum stress in LPL gene knockout heterozygous mice
Li, Y., Han, T.-T., Liu, Y., Zheng, S., Zhang, Y., Liu, W., & Hu, Y. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.020 · Cited by 37
Correlation of anthropometric indicators for identifying insulin sensitivity and resistance
de Matos, L. N., Giorelli, G., & Dias, C. B. (2011) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802011000100006 · Cited by 36
High blood pressure and the incidence of non-insulin dependent diabetes mellitus: Findings in A 11.5 year follow-up study in the Netherlands
Stolk, R. P., van Splunder, I. P., Schouten, J., Witteman, J. C. M., Hofman, A., & Grobbee, D. E. (1993) · European Journal of Epidemiology · doi:10.1007/bf00158782 · Cited by 37
Hyperinsulinemia and Cardiovascular Disease in Elderly Men
Burchfiel, C. M., Sharp, D. S., Curb, J. D., Rodríguez, B. L., Abbott, R. D., Arakaki, R. F., & Yano, K. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.3.450 · Cited by 38
Fasting plasma glucose in non‐diabetic elderly women predicts increased all‐causes mortality and coronary heart disease risk
Simons, L. A., Friedlander, Y., McCallum, J. C., & Simons, J. A. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb01053.x · Cited by 37
The TZD insulin sensitizer clue provides a new route into diabetes drug discovery
Colca, J. R. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1100164 · Cited by 37
Separate and combined associations of physical activity and obesity with lipid-related indices in non-diabetic and diabetic patients
Zhang, Y., Yang, J., Ye, J., Guo, Q., Wang, W., Sun, Y., & Zeng, Q. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0987-6 · Cited by 36
Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats
Lee, J. H., Xia, S., & Ragolia, L. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00191.2008 · Cited by 36
Diabetes and Associated Risk Factors in Patients Referred for Physical Therapy in a National Primary Care Electronic Medical Record Database
Kirkness, C. S., Marcus, R. L., LaStayo, P. C., Asche, C. V., & Fritz, J. M. (2008) · Physical Therapy · doi:10.2522/ptj.20080129 · Cited by 36
Trajectories of Long‐Term Normal Fasting Plasma Glucose and Risk of Coronary Heart Disease: A Prospective Cohort Study
Yuan, Z., Yang, Y., Wang, C., Liu, J., Sun, X., Liu, Y., Li, S., & Xue, F. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007607 · Cited by 36
Coronary Artery Disease Risk Predicted by Insulin Resistance, Plasma Lipids, and Hypertension In People without Diabetes
Sheu, W. H., Jeng, C.-Y., Young, M. S., Lee, W., & Chen, Y. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40693-7 · Cited by 35
Reversing the tide — diagnosis and prevention of T2DM in populations of African descent
Utumatwishima, J. N., Chung, S. T., Bentley, A. R., Udahogora, M., & Sumner, A. E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.127 · Cited by 36
Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection
Otamas, A., Grant, P. J., & Ajjan, R. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120920582 · Cited by 39
Cardiovascular disease in patients who have diabetes
Goldberg, R. B. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00074-2 · Cited by 36
Determinants for the progression from impaired glucose tolerance to non‐insulin‐dependent diabetes mellitus
Nijpels (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.0280s2008.x · Cited by 34
Syndrome X: A syndrome of insulin resistance. Epidemiological and clinical evidence
WAJCHENBERG, B. L., Malerbi, D. A. C., Lerário, A. C., Santomauro, A. T. M. G., & Rocha, M. D. S. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100103 · Cited by 34
Prevalence of silent myocardial ischaemia in new‐onset middle‐aged Type 2 diabetic patients without other cardiovascular risk factors
Fornengo, P., Bosio, A., Epifani, G., Pallisco, O., Mancuso, A., & Pascale, C. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01910.x · Cited by 35
Diabetes Mellitus and Coronary Heart Disease in the Elderly
Vokonas, P., & Kannel, W. B. (1996) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30245-3 · Cited by 33
Acarbose ameliorates atherogenecity of low-density lipoprotein in patients with impaired glucose tolerance
Inoue, I., Shinoda, Y., Nakano, T., Sassa, M., Goto, S.-I., Awata, T., Komoda, T., & Katayama, S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.002 · Cited by 34
Glycaemic variability and inflammation in subjects with metabolic syndrome
Buscemi, S., Verga, S., Cottone, S., Azzolina, V., Buscemi, B., Gioia, D., & Cerasola, G. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0061-8 · Cited by 34
Coronary heart disease and diabetic retinopathy in newly diagnosed diabetes in Da Qing, China: The Da Qing IGT and Diabetes Study
Hu, Y., Pan, X.-R., Ping-an, L., Li, G.-W., Howard, B. V., & Bennett, P. H. (1991) · Acta Diabetologica · doi:10.1007/bf00579721 · Cited by 34
Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT Study in Norway
Dale, A. C., Midthjell, K., Nilsen, T. I. L., Wiseth, R., & Vatten, L. J. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp039 · Cited by 34
Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk
Aroner, S. A., Yang, M., Li, J., Furtado, J. D., Sacks, F. M., Tjønneland, A. M., Overvad, K., Cai, T., & Jensen, M. K. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx143 · Cited by 34
Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients
Strisciuglio, T., Izzo, R., Barbato, E., Gioia, G. D., Colaiori, I., Fiordelisi, A., Morisco, C., Bartúnek, J., Franco, D., Ammirati, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072144 · Cited by 33
Case-Control Study of Diabetes Mellitus in HIV-Infected Patients
Yoon, C. J., Gulick, R. M., Hoover, D. R., Vaamonde, C., & Glesby, M. J. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000137373.26438.18 · Cited by 33
The potential metabolic consequences of cerebral palsy: inferences from the general population and persons with spinal cord injury
Bauman, W. A. (2009) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2009.03430.x · Cited by 35
Importance and Management of Dyslipidemia in the Metabolic Syndrome
Menuet, R., Lavie, C. J., & Milani, R. V. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00007 · Cited by 33
Insulin Resistance, Compensatory Hyperinsulinemia, and Coronary Heart Disease: Syndrome X Revisited
Reaven, G. M. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070238 · Cited by 32
Coronary calcification, homocysteine, C‐reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study
Godsland, I. F., Elkeles, R. S., Feher, M. D., Nugara, F., Rubens, M., Richmond, W., Khan, M. N., Donovan, J., Anyaoku, V., Flather, M. D., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01950.x · Cited by 32
Early-Adulthood Cardiovascular Disease Risk Factor Profiles Among Individuals With and Without Diabetes in the Framingham Heart Study
Preis, S. R., Pencina, M. J., Mann, D. M., D’Agostino, R. B., Savage, P. J., & Fox, C. S. (2013) · Diabetes Care · doi:10.2337/dc12-1121 · Cited by 31
Utility of serum lipid ratios for predicting incident type 2 diabetes: the Isfahan Diabetes Prevention Study
Janghorbani, M., & Amini, M. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2770 · Cited by 31
HDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial Hypertension
Jonas, K., & Kopeć, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143514 · Cited by 31
Chronic kidney disease as a cardiovascular risk factor
Carmena, R., Ascaso, J. F., & Redón, J. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002506 · Cited by 33
Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women
Reyes‐López, R., Pérez-Luque, E. L., & Malacara, J. M. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2538 · Cited by 31
Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance
Flowers, J. B., Oler, A. T., Nadler, S. T., Choi, Y., Schueler, K. L., Yandell, B. S., Kendziorski, C. M., & Attie, A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00370.2006 · Cited by 33

Authors: Haffner, S. M.
Corresponding author: Haffner, Steven M.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 1990-06-06
Volume: 263
Issue: 21
Pages: 2893
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1990.03440210043030
OpenAlex: W4297681290
Cited by: 668
References: 0
Citations by year: 2026: 3 · 2025: 9 · 2024: 14 · 2023: 9 · 2022: 18 · 2021: 12 · 2020: 23 · 2019: 15 · 2018: 16 · 2017: 14 · 2016: 17 · 2015: 25 · 2014: 21 · 2013: 16 · 2012: 22
FWCI: 6.93
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: prediabetes, type 2 diabetes, cardiovascular risk factors, hyperinsulinemia, atherogenic lipid profile, impaired glucose tolerance, macrovascular complications, Mexican Americans, San Antonio Heart Study, fasting insulin, obesity, disease duration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks